SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021325
Filing Date
2020-11-13
Accepted
2020-11-13 16:30:31
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 406547
2 ex31-1.htm EX-31.1 10644
3 ex31-2.htm EX-31.2 10713
4 ex32-1.htm EX-32.1 9244
  Complete submission text file 0001493152-20-021325.txt   3079440

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cocp-20200930.xml EX-101.INS 486163
6 XBRL SCHEMA FILE cocp-20200930.xsd EX-101.SCH 47567
7 XBRL CALCULATION FILE cocp-20200930_cal.xml EX-101.CAL 48469
8 XBRL DEFINITION FILE cocp-20200930_def.xml EX-101.DEF 157898
9 XBRL LABEL FILE cocp-20200930_lab.xml EX-101.LAB 325832
10 XBRL PRESENTATION FILE cocp-20200930_pre.xml EX-101.PRE 228817
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 201311914
SIC: 2834 Pharmaceutical Preparations